Parametric Risk Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
$7.4M Hold
137,272
0.5% 37
2016
Q2
$10.1M Hold
137,272
0.66% 33
2016
Q1
$8.77M Buy
137,272
+15,000
+12% +$946K 0.6% 35
2015
Q4
$8.41M Buy
122,272
+40,000
+49% +$2.64M 0.58% 29
2015
Q3
$4.87M Buy
82,272
+26,000
+46% +$1.65M 0.32% 43
2015
Q2
$3.74M Hold
56,272
0.25% 55
2015
Q1
$3.63M Hold
56,272
0.25% 58
2014
Q4
$3.32M Hold
56,272
0.22% 64
2014
Q3
$2.88M Buy
56,272
+6,272
+13% +$313K 0.19% 71
2014
Q2
$2.43M Buy
+50,000
New +$2.46M 0.16% 81

Other funds holding BMY

Parametric Risk Advisors's BMY Position: Q3 2016 in Review

Parametric Risk Advisors held its Bristol-Myers Squibb (BMY) position steady in Q3 2016 at 137,272 shares worth $7.4M. The position accounts for 0.5% of the portfolio, ranked #37.

Parametric Risk Advisors first reported a position in BMY in Q2 2014 and has held it in 10 quarters since. The position peaked at $10.1M in Q2 2016. 1,522 funds tracked by Wall St. Rank hold BMY as of Q3 2016.

  • Parametric Risk Advisors held 137,272 shares of Bristol-Myers Squibb worth $7.4M as of Q3 2016.
  • Parametric Risk Advisors left its Bristol-Myers Squibb share count unchanged in Q3 2016.
  • Bristol-Myers Squibb made up 0.5% of Parametric Risk Advisors's portfolio in Q3 2016, its #37 holding.
  • Parametric Risk Advisors first reported a position in Bristol-Myers Squibb in Q2 2014 and has held it in 10 quarters since.
  • Parametric Risk Advisors's Bristol-Myers Squibb position peaked at $10.1M in Q2 2016.
  • 1,522 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2016.

Based on Parametric Risk Advisors's 13F filing for Q3 2016, filed 14 Nov 2016.